This study is the first to demonstrate that LC3 expression in the non-tumor liver microenvironment is significantly associated with HCC recurrence and that the low LC3 expression in both tumor and ANT tissues significantly increases the risk of HCC recurrence. Here, MAP1LC3A is linked to hepatocellular carcinoma.